Search results
Showing 91 to 105 of 372 results for kidney
referral criteria and shared care: What is the accuracy of the 4-variable Kidney Failure Risk Equation in children and young people...
In development Reference number: GID-TA11554 Expected publication date: TBC
Evidence-based recommendations on dapagliflozin for treating chronic kidney disease in adults.
diagnostic accuracy of cystatin-C equations to estimate GFR as a measurement of kidney function in adults, young people and children in...
Evidence-based recommendations on DyeVert Systems for reducing the risk of acute kidney injury in coronary and peripheral angiography.
Recommendation ID NG106/4 Question The impact of advanced kidney disease on the natriuretic peptide threshold for diagnosing heart...
Evidence-based recommendations on migalastat (Galafold) for treating Fabry disease in people over 16.
Irreversible electroporation for treating liver metastases (HTG304)
Evidence-based recommendations on irreversible electroporation for the treatment of liver metastases. This involves using very short electrical field pulses delivered over several minutes to destroy the tumour and a small surrounding tissue margin.
View recommendations for HTG304Show all sections
Sections for HTG304
Fetal cystoscopy for the diagnosis and treatment of lower urinary outflow tract obstruction (HTG131)
Evidence-based recommendations on fetal cystoscopy for the diagnosis and treatment of lower urinary outflow tract obstruction. This involves inserting a tube with a flexible camera through small cuts in the mother's abdomen to identify and open any blockage.
View recommendations for HTG131Show all sections
Sections for HTG131
Burosumab for treating X-linked hypophosphataemia in children and young people (HST8)
Evidence-based recommendations on burosumab (Crysvita) for X-linked hypophosphataemia in children and young people.
Ravulizumab for treating atypical haemolytic uraemic syndrome (TA710)
Evidence-based recommendations on ravulizumab (Ultomiris) for treating atypical haemolytic uraemic syndrome in people weighing 10 kg or more.
Asian and minority ethnic groups: What is the accuracy of the 4-variable Kidney Failure Risk Equation in adults, children and young...
infusion NICE approves breakthrough combination treatment that restores normal kidney function in almost half of patients with lupus...
Percutaneous nephrolithotomy for kidney stones greater than 1.5cm
Topic prioritisation
Minimally invasive percutaneous nephrolitholapaxy medium (MIP-M) for removing kidney stones (MIB138)
NICE has developed a medtech innovation briefing (MIB) on minimally invasive percutaneous nephrolitholapaxy medium (MIP-M) for removing kidney stones .